Sonde Health

Sonde HealthSonde Health
SH

Sonde Health

AI-powered vocal biomarker platform for early detection and monitoring of health conditions.

DR 422015ActiveBoston, United States
Rate

About

Sonde Health leverages voice AI to analyze everyday conversations, detecting changes in vocal biomarkers that indicate mental, cognitive, and respiratory health. Their clinically validated platform provides organizations with continuous, actionable health insights through an API/SDK, enabling proactive health management and risk stratification for their users. This technology aims to improve outcomes by identifying early health issues and supporting workforce well-being.
Frequently asked

What does Sonde Health do?

Sonde Health leverages voice AI to analyze everyday conversations, detecting changes in vocal biomarkers that indicate mental, cognitive, and respiratory health. Their clinically validated platform provides organizations with continuous, actionable health insights through an API/SDK, enabling proactive health management and risk stratification for their users. This technology aims to improve outcomes by identifying early health issues and supporting workforce well-being.

What is Sonde Health's revenue?

StartupHub estimates Sonde Health's annual revenue at $9.3M (range $5.7M to $33.9M, 29% confidence), based on comparable companies in the sector.

What is Sonde Health's valuation?

StartupHub estimates Sonde Health's effective valuation at $142.4M (range $88.1M to $211.5M, 10% confidence), based on comparable companies in the sector.

How much funding has Sonde Health raised?

Sonde Health has raised a total of $35M in funding. The most recent round on record is Series B.

Where is Sonde Health headquartered?

Sonde Health is headquartered in Boston, United States.

When was Sonde Health founded?

Sonde Health was founded in 2015.

What industry does Sonde Health operate in?

Sonde Health operates in HealthTech, AI, SaaS, Digital Health, Vocal Biomarkers, Voice Agent.

Comments

No comments yet. Be the first to share your take.